학술논문
Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
Document Type
Article
Author
Source
In Journal of Thoracic Oncology April 2021 16(4):643-652
Subject
Language
ISSN
1556-0864